User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 4 results.
    • Speech
    A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study
    Westhovens, Rene[UCL] Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Vastesaeger, N. (2004) Annual European Congress of Rheumatology (EULAR 2004) — Berlin (Germany)
    • Journal article
    Timing of DAS28 in infliximab therapy: reply
    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 9, p. 1204-1204 (2005)
    • Journal article
    A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 4, p. 465-468 (2005)
    • Speech
    Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis.
    Durez, Patrick[UCL] Vandenbosch, F. Corluy, L Van den Bossche, N Schuerwegh, A De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Westhovens, Rene[UCL] (2002) 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — NEW ORLEANS (Louisiana)